Casey C. Kopczynski Ph.D. — Co-Founder & Chief Scientific Officer at Aerie Pharmaceuticals

Dr. Casey C. Kopczynski, PhD, Co-Founded Aerie Pharmaceuticals, Inc. in 2005 and has been its Chief Scientific Officer since formation. Dr. Kopczynski served as Chief Operating Officer and Chief Research Officer at Aerie Pharmaceuticals, Inc. He has 18 years of research and management experience to Aerie, including nine years with early stage life science companies. Prior to Aerie, he was Managing Partner at Biotech Initiative, LLC, a consulting practice dedicated to emerging biotech companies. Dr. Kopczynski was previously Vice President of Research at Ercole Biotech, Inc., an early stage company developing novel drugs for the treatment of cancer, inflammation and orphan genetic diseases. Prior to Ercole Biotech, Dr. Kopczynski was Director of Research and a founding member of the scientific staff at Exelixis, Inc. (EXEL). There he worked with the management team to grow the organization from 10 employees to over 500. His responsibilities included building and managing a team of 95 scientists focused on target discovery and validation. He received his PhD in Molecular, Cellular and Developmental Biology from Indiana University and was a Jane Coffin Childs Research Fellow at the University of California, Berkeley.